Ofer Spiegelstein

Ofer Spiegelstein is a seasoned professional in clinical pharmacology with extensive experience in pharmaceutical development and research. Currently serving as VP of Clinical Pharmacology at Ventus Therapeutics since December 2022, Ofer is responsible for designing and leading first-in-human studies and overseeing bioanalysis for pharmacokinetic and pharmacodynamic evaluation. Previous roles include consulting for pharma and biotech companies at Focused Consulting, leading preclinical pharmacology at Tamarix Pharma, and managing early phase development at BOL Pharma. Ofer's tenure at Teva Pharmaceuticals spanned over 16 years in various leadership roles, including Vice President of Innovation and Global Head of Clinical Pharmacology. Academic credentials include a PhD in Pharmaceutical Sciences, an MSc in Clinical Pharmacy, and a B Pharm in Pharmacy, all from The Hebrew University of Jerusalem.